Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | SELP | P16109 | 1/20 | 0.34 |
| ▸ | BCHE | P06276 | 4/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1673967 | 0.92 | L3MBTL1 (0.63) | L3MBTL1KMT2AMEN1ALDH1A1PKM | |
| SCHEMBL21394382 | 0.88 | L3MBTL1 (0.51) | L3MBTL1KMT2AMEN1ALDH1A1LMNA | |
| SCHEMBL26520261 | 0.88 | L3MBTL1 (0.47) | L3MBTL1KMT2AMEN1ALDH1A1SELP | |
| SCHEMBL26103983 | 0.88 | L3MBTL1 (0.47) | L3MBTL1KMT2AMEN1ALDH1A1SELP | |
| SCHEMBL11211811 | 0.86 | L3MBTL1 (0.53) | L3MBTL1KMT2AMEN1ALDH1A1SELP | |
| SCHEMBL21381181 | 0.86 | L3MBTL1 (0.59) | L3MBTL1KMT2AMEN1ALDH1A1PKM | |
| SCHEMBL8058114 | 0.86 | L3MBTL1 (0.59) | L3MBTL1KMT2AMEN1ALDH1A1PKM | |
| SCHEMBL21394611 | 0.86 | L3MBTL1 (0.59) | L3MBTL1KMT2AMEN1ALDH1A1PKM | |
| SCHEMBL14468744 | 0.86 | L3MBTL1 (0.59) | L3MBTL1KMT2AMEN1ALDH1A1PKM | |
| SCHEMBL13650802 | 0.86 | L3MBTL1 (0.59) | L3MBTL1KMT2AMEN1ALDH1A1PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9695208-B2 | Sialic acid (A-(2-6))-D-aminopyranose derivatives, synthesis methods and uses thereof | PEKING UNIVERSITY (CN) | 2017-07-04 | — | — | US | disclosed |
| EP-2581380-B1 | SIALIC ACID (alpha-(2-6))-D-AMINOPYRANOSE DERIVATIVES, SYNTHESIS METHODS AND USES THEREOF | UNIV BEIJING (CN) | 2017-06-07 | — | — | EP | disclosed |
| EP-2581380-A1 | SIALIC ACID ( -(2 6)-D-AMINOPYRANOSE DERIVATIVES, SYNTHESIS METHODS AND USES THEREOF | Peking University (CN) | 2013-04-17 | — | — | EP | disclosed |
| US-20130079291-A1 | SIALIC ACID (A-(2-6))-D-AMINOPYRANOSE DERIVATIVES, SYNTHESIS METHODS AND USES THEREOF | PEKING UNIVERSITY (CN) | 2013-03-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130079291-A1 | SIALIC ACID (A-(2-6))-D-AMINOPYRANOSE DERIVATIVES, SYNTHESIS METHODS AND USES THEREOF | ST6GAL1, FUT6, B3GNT2 | L3MBTL1 3833/4885KMT2A 3474/4885MEN1 3322/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.